Articles with "hfpef patients" as a keyword



Photo by sharonmccutcheon from unsplash

Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.

Sign Up to like & get
recommendations!
Published in 2022 at "ESC heart failure"

DOI: 10.1002/ehf2.13885

Abstract: AIMS The aim of this study was to elucidate the clinical characteristics, including frailty status, of patients with heart failure with preserved ejection fraction (HFpEF) in comparison with those in patients with heart failure with… read more here.

Keywords: hfpef patients; ejection fraction; frailty; hfref patients ... See more keywords
Photo by freestocks from unsplash

Impact of different training modalities on high‐density lipoprotein function in HFpEF patients: a substudy of the OptimEx trial

Sign Up to like & get
recommendations!
Published in 2022 at "ESC Heart Failure"

DOI: 10.1002/ehf2.14032

Abstract: In heart failure with preserved ejection fraction (HFpEF), the reduction of nitric oxide (NO)‐bioavailability and consequently endothelial dysfunction leads to LV stiffness and diastolic dysfunction of the heart. Besides shear stress, high‐density lipoprotein (HDL) stimulates… read more here.

Keywords: high density; density lipoprotein; heart; hfpef patients ... See more keywords
Photo from wikipedia

Endothelial dysfunction and cellular repair in heart failure with preserved ejection fraction: response to a single maximal exercise bout

Sign Up to like & get
recommendations!
Published in 2019 at "European Journal of Heart Failure"

DOI: 10.1002/ejhf.1339

Abstract: Recent evidence implicates the endothelium as a central mediator in the development of heart failure with preserved ejection fraction (HFpEF).1 Co-morbidities such as hypertension, diabetes mellitus and obesity induce an inflammatory state and reduce nitric… read more here.

Keywords: heart; hfpef patients; dysfunction; hfpef ... See more keywords
Photo from wikipedia

Risk stratification in hospitalized heart failure patients: do the RIGHT thing!

Sign Up to like & get
recommendations!
Published in 2019 at "Internal and Emergency Medicine"

DOI: 10.1007/s11739-019-02121-4

Abstract: Heart failure with preserved ejection fraction (HFpEF) is intended to become a major challenge in the upcoming years for all clinicians. According to American forecasts, HFpEF prevalence will probably rise up by 2050 to 60%… read more here.

Keywords: medicine; heart; hfpef patients; heart failure ... See more keywords
Photo from wikipedia

Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.

Sign Up to like & get
recommendations!
Published in 2022 at "Atherosclerosis"

DOI: 10.1016/j.atherosclerosis.2022.01.013

Abstract: BACKGROUND AND AIMS Heart failure with preserved ejection fraction (HFpEF) patients have a high burden of comorbidities that could predispose them to ischemic vascular event. The profile of ischemic risk among HFpEF patients is not… read more here.

Keywords: hfpef patients; risk; event; failure preserved ... See more keywords
Photo by nci from unsplash

A COMPOSITE METRIC TO IDENTIFY HFPEF PATIENTS LIKELY TO BENEFIT FROM SPIRONOLACTONE

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of the American College of Cardiology"

DOI: 10.1016/s0735-1097(20)31308-5

Abstract: The TOPCAT trial, overall, showed no benefit for spironolactone in heart failure patients with preserved ejection fraction (HFpEF). Post-hoc, spironolactone helped participants from the Americas but not Eastern Europe, potentially due to differences in baseline… read more here.

Keywords: identify hfpef; composite metric; hfpef patients; benefit spironolactone ... See more keywords
Photo by sharonmccutcheon from unsplash

Electrophysiological findings in HFpEF patients presenting for AF ablation

Sign Up to like & get
recommendations!
Published in 2023 at "Europace"

DOI: 10.1093/europace/euad122.049

Abstract: Abstract Funding Acknowledgements Type of funding sources: None. Aims The prevalence of atrial fibrillation (AF) in heart failure with preserved ejection fraction (HFpEF) patients is high. Impaired left atrial (LA) function is a major determinant… read more here.

Keywords: bipolar voltage; low voltage; hfpef patients; hfpef ... See more keywords
Photo from wikipedia

A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS OF PDE5 INHIBITOR SILDENAFIL IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Hypertension"

DOI: 10.1097/01.hjh.0000835912.44478.14

Abstract: Objective: he results of clinical trials of phosphodiesterase (PDE) 5 inhibitors for the treatment of HFpEF patients are inconsistent. Thus, we undertook a meta-analysis to evaluate the clinical value of sildenafil for HF with preserved… read more here.

Keywords: meta analysis; hfpef patients; hfpef; sildenafil ... See more keywords
Photo by aminmoshrefi from unsplash

CORRELATION OF BLOOD PRESSURE CHANGES WITH THE FUNCTIONAL CAPACITY IN HEART FAILURE PATIENTS WITH PRESERVED AND MID-RANGE EJECTION FRACTION

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Hypertension"

DOI: 10.1097/01.hjh.0000836316.10535.6b

Abstract: Objective: 6-minute walk test (6-MWT) reflects the daily activity of heart failure (HF) patients who develop progressive limitation of functional capacity (FC). Our aim was to assess different blood pressure (BP) parameters and their changes… read more here.

Keywords: hfmef; pressure; blood pressure; hfpef patients ... See more keywords
Photo from wikipedia

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation

Sign Up to like & get
recommendations!
Published in 2020 at "Cardiology Research and Practice"

DOI: 10.1155/2020/3059864

Abstract: Background There are no proven effective treatments that can reduce the mortality in heart failure with preserved ejection fraction (HFpEF), probably due to its heterogeneous nature which will weaken the effect of therapy in clinical… read more here.

Keywords: hfpef patients; blocker treatment; mortality; blocker ... See more keywords
Photo from wikipedia

The Relationship between Angiotensin–Neprilysin Treatment, Echocardiographic Parameters, and NT-proBNP Levels in HFpEF Patients with Acute Decompensated Heart Failure

Sign Up to like & get
recommendations!
Published in 2022 at "Computational and Mathematical Methods in Medicine"

DOI: 10.1155/2022/4298644

Abstract: Background The valsartan-sacubitril therapy improved the outcomes of patients with acute decompensated heart failure (ADHF) of a reduced ejection fraction (HFrEF). In ADHF patients with preserved ejection fraction (HFpEF), it is not yet clear whether… read more here.

Keywords: hfpef patients; decompensated heart; treatment; patients acute ... See more keywords